Shanghai Pharmaceuticals Holding Co Ltd Financial Flexibility Index
Shanghai Pharmaceuticals Holding Co Ltd financial flexibility index. Shanghai Pharmaceuticals Holding Co Ltd (601607) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of CN¥2.05 Billion (operating CF CN¥1.56 Billion minus capex CN¥487.63 Million) represents 0% of total liabilities (CN¥147.12 Billion). See Shanghai Pharmaceuticals Holding Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Shanghai Pharmaceuticals Holding Co Ltd (1998–2025)
Financial flexibility index of Shanghai Pharmaceuticals Holding Co Ltd from 1998 to 2025. Historical Financial Flexibility Index trend for Shanghai Pharmaceuticals Holding Co Ltd across 28 annual periods. Check Shanghai Pharmaceuticals Holding Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Shanghai Pharmaceuticals Holding Co Ltd Financial Flexibility Index by Year (1998–2025)
Shanghai Pharmaceuticals Holding Co Ltd financial flexibility index by year from 1998 to 2025. Year-by-year free cash flow to debt coverage for Shanghai Pharmaceuticals Holding Co Ltd. For the full cash flow conversion analysis, see 601607 cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | CN¥8.48 Billion | CN¥6.15 Billion | CN¥143.36 Billion | ▼ -1.2% |
| 2024 | 0.06x | CN¥8.23 Billion | CN¥5.83 Billion | CN¥137.47 Billion | ▼ -3.9% |
| 2023 | 0.06x | CN¥8.20 Billion | CN¥5.23 Billion | CN¥131.65 Billion | ▲ +0.8% |
| 2022 | 0.06x | CN¥7.43 Billion | CN¥4.74 Billion | CN¥120.13 Billion | ▼ -29.7% |
| 2021 | 0.09x | CN¥9.18 Billion | CN¥5.06 Billion | CN¥104.37 Billion | ▼ -15.7% |
| 2020 | 0.10x | CN¥9.85 Billion | CN¥6.84 Billion | CN¥94.44 Billion | ▲ +4.2% |
| 2019 | 0.10x | CN¥8.78 Billion | CN¥6.02 Billion | CN¥87.64 Billion | ▲ +58.6% |
| 2018 | 0.06x | CN¥5.08 Billion | CN¥3.14 Billion | CN¥80.45 Billion | ▼ -25.9% |
| 2017 | 0.09x | CN¥4.66 Billion | CN¥2.65 Billion | CN¥54.67 Billion | ▼ -3.8% |
| 2016 | 0.09x | CN¥4.07 Billion | CN¥1.95 Billion | CN¥45.91 Billion | ▲ +17.0% |
| 2015 | 0.08x | CN¥3.07 Billion | CN¥1.35 Billion | CN¥40.54 Billion | ▼ -4.2% |
| 2014 | 0.08x | CN¥2.63 Billion | CN¥1.34 Billion | CN¥33.24 Billion | ▲ +14.9% |
| 2013 | 0.07x | CN¥1.88 Billion | CN¥973.45 Million | CN¥27.31 Billion | ▼ -13.6% |
| 2012 | 0.08x | CN¥1.86 Billion | CN¥1.15 Billion | CN¥23.37 Billion | ▼ -21.0% |
| 2011 | 0.10x | CN¥2.19 Billion | CN¥1.77 Billion | CN¥21.69 Billion | ▼ -26.6% |
| 2010 | 0.14x | CN¥2.24 Billion | CN¥1.69 Billion | CN¥16.28 Billion | ▲ +16.9% |
| 2009 | 0.12x | CN¥744.10 Million | CN¥664.13 Million | CN¥6.33 Billion | ▲ +76.9% |
| 2008 | 0.07x | CN¥376.18 Million | CN¥285.68 Million | CN¥5.67 Billion | ▼ -49.6% |
| 2007 | 0.13x | CN¥681.23 Million | CN¥488.94 Million | CN¥5.17 Billion | ▼ -17.3% |
| 2006 | 0.16x | CN¥734.71 Million | CN¥583.11 Million | CN¥4.61 Billion | ▲ +156.8% |
| 2005 | 0.06x | CN¥271.09 Million | CN¥73.00 Million | CN¥4.37 Billion | ▼ -13.6% |
| 2004 | 0.07x | CN¥316.05 Million | CN¥61.66 Million | CN¥4.40 Billion | ▲ +70.0% |
| 2003 | 0.04x | CN¥170.07 Million | CN¥484.27K | CN¥4.03 Billion | ▼ -62.2% |
| 2002 | 0.11x | CN¥380.28 Million | CN¥100.84 Million | CN¥3.40 Billion | ▲ +31.4% |
| 2001 | 0.09x | CN¥210.44 Million | CN¥65.73 Million | CN¥2.47 Billion | ▼ -24.5% |
| 2000 | 0.11x | CN¥287.31 Million | CN¥146.22 Million | CN¥2.55 Billion | ▲ +14.4% |
| 1999 | 0.10x | CN¥217.15 Million | CN¥164.67 Million | CN¥2.21 Billion | ▲ +265.0% |
| 1998 | -0.06x | CN¥-113.25 Million | CN¥-283.14 Million | CN¥1.90 Billion | — |